PE20091022A1 - Anticuerpos anti-factor b y sus usos - Google Patents
Anticuerpos anti-factor b y sus usosInfo
- Publication number
- PE20091022A1 PE20091022A1 PE2008001904A PE2008001904A PE20091022A1 PE 20091022 A1 PE20091022 A1 PE 20091022A1 PE 2008001904 A PE2008001904 A PE 2008001904A PE 2008001904 A PE2008001904 A PE 2008001904A PE 20091022 A1 PE20091022 A1 PE 20091022A1
- Authority
- PE
- Peru
- Prior art keywords
- factor
- antibody
- humanized
- diabetic
- life chain
- Prior art date
Links
- 208000005590 Choroidal Neovascularization Diseases 0.000 abstract 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 abstract 1
- 206010012688 Diabetic retinal oedema Diseases 0.000 abstract 1
- 206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
- 206010064930 age-related macular degeneration Diseases 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 208000001309 degenerative myopia Diseases 0.000 abstract 1
- 230000004340 degenerative myopia Effects 0.000 abstract 1
- 201000011190 diabetic macular edema Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 210000001624 hip Anatomy 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US264807P | 2007-11-08 | 2007-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20091022A1 true PE20091022A1 (es) | 2009-07-16 |
Family
ID=40344464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001904A PE20091022A1 (es) | 2007-11-08 | 2008-11-07 | Anticuerpos anti-factor b y sus usos |
Country Status (15)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011003098A1 (en) | 2009-07-02 | 2011-01-06 | Musc Foundation For Research Development | Methods of stimulating liver regeneration |
| TWI407953B (zh) * | 2011-03-24 | 2013-09-11 | Univ Kaohsiung Medical | 用於調節補體因子ｂ（ｃｆｂ）表現的醫藥組合物 |
| US9803005B2 (en) | 2012-05-24 | 2017-10-31 | Alexion Pharmaceuticals, Inc. | Humaneered anti-factor B antibody |
| CN114890943A (zh) | 2013-11-15 | 2022-08-12 | 阿克比治疗有限公司 | {[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基}乙酸固体形式，组合物和用途 |
| EA201892225A1 (ru) | 2016-04-04 | 2019-09-30 | БИОВЕРАТИВ ЮЭсЭй ИНК. | АНТИТЕЛА К ФАКТОРУ Bb КОМПЛЕМЕНТА И ИХ ПРИМЕНЕНИЕ |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
| AU2021261257A1 (en) | 2020-04-20 | 2022-12-22 | Genzyme Corporation | Humanized anti-complement factor Bb antibodies and uses thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| JP3040121B2 (ja) | 1988-01-12 | 2000-05-08 | ジェネンテク，インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
| EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| DK1136556T3 (da) | 1991-11-25 | 2005-10-03 | Enzon Inc | Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner |
| DE69329503T2 (de) | 1992-11-13 | 2001-05-03 | Idec Pharma Corp | Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma |
| EP1513879B1 (en) | 2002-06-03 | 2018-08-22 | Genentech, Inc. | Synthetic antibody phage libraries |
| US20070123466A1 (en) * | 2003-05-13 | 2007-05-31 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Method of treating recurrent miscarriages |
| DK1713503T3 (da) * | 2004-02-10 | 2013-11-04 | Univ Colorado Regents | Hæmning af faktor b, den alternative komplemenpathway og dertil relaterede fremgangsmåde |
| NZ567483A (en) | 2005-11-04 | 2012-04-27 | Genentech Inc | Use of complement pathway inhibitors to treat ocular diseases |
| DK1991275T3 (en) | 2006-03-08 | 2014-12-08 | Archemix Llc | Complement aptamers AND ANTI-C5 AGENTS FOR USE IN THE TREATMENT OF EYE DISEASES |
| EP2134173A4 (en) | 2007-03-01 | 2010-11-10 | Wellstat Ophthalmics Corp | TREATMENT OF DISEASES SIGNED BY IGNITION |
-
2008
- 2008-11-06 AU AU2008323939A patent/AU2008323939A1/en not_active Abandoned
- 2008-11-06 JP JP2010533241A patent/JP2011503094A/ja active Pending
- 2008-11-06 KR KR1020107012466A patent/KR20100105587A/ko not_active Withdrawn
- 2008-11-06 CA CA2704973A patent/CA2704973A1/en not_active Abandoned
- 2008-11-06 MX MX2010005115A patent/MX2010005115A/es unknown
- 2008-11-06 CN CN2008801243361A patent/CN101918444A/zh active Pending
- 2008-11-06 EP EP08848036A patent/EP2209807A1/en not_active Withdrawn
- 2008-11-06 US US12/291,222 patent/US8158762B2/en not_active Expired - Fee Related
- 2008-11-06 WO PCT/US2008/082621 patent/WO2009061910A1/en not_active Ceased
- 2008-11-06 BR BRPI0820343A patent/BRPI0820343A2/pt not_active IP Right Cessation
- 2008-11-07 CL CL2008003313A patent/CL2008003313A1/es unknown
- 2008-11-07 TW TW097143224A patent/TW200927170A/zh unknown
- 2008-11-07 AR ARP080104888A patent/AR069233A1/es not_active Application Discontinuation
- 2008-11-07 PE PE2008001904A patent/PE20091022A1/es not_active Application Discontinuation
-
2010
- 2010-05-06 IL IL205577A patent/IL205577A0/en unknown
-
2012
- 2012-01-31 US US13/385,057 patent/US20120230997A1/en not_active Abandoned
-
2015
- 2015-10-06 US US14/876,655 patent/US20160024224A1/en not_active Abandoned
-
2017
- 2017-10-23 US US15/791,064 patent/US20180037667A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20180037667A1 (en) | 2018-02-08 |
| CL2008003313A1 (es) | 2010-02-05 |
| JP2011503094A (ja) | 2011-01-27 |
| WO2009061910A1 (en) | 2009-05-14 |
| AU2008323939A1 (en) | 2009-05-14 |
| TW200927170A (en) | 2009-07-01 |
| CA2704973A1 (en) | 2009-05-14 |
| US20120230997A1 (en) | 2012-09-13 |
| US20090123469A1 (en) | 2009-05-14 |
| IL205577A0 (en) | 2010-11-30 |
| US20160024224A1 (en) | 2016-01-28 |
| US8158762B2 (en) | 2012-04-17 |
| EP2209807A1 (en) | 2010-07-28 |
| KR20100105587A (ko) | 2010-09-29 |
| CN101918444A (zh) | 2010-12-15 |
| MX2010005115A (es) | 2010-05-27 |
| AR069233A1 (es) | 2010-01-06 |
| BRPI0820343A2 (pt) | 2017-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20091022A1 (es) | Anticuerpos anti-factor b y sus usos | |
| PE20190389A1 (es) | Composiciones y metodos de inhibicion del masp-3 para el tratamiento de diversas enfermedades y trastornos | |
| PE20200734A1 (es) | Anticuerpos anti-tgf-beta y su uso | |
| PE20120899A1 (es) | Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c3b | |
| PH12020552178A1 (en) | Anti-il36r antibodies | |
| PE20211786A1 (es) | Anticuerpos humanizados contra c-kit | |
| DOP2014000007A (es) | Proteinas de union a antigeno de tnf-alfa con union a fcrn incrementada | |
| PE20090294A1 (es) | Composicion farmaceutica que comprende un antagonista del factor d y su uso en el tratamiento de condiciones oculares | |
| MA40182A (fr) | NOUVEL ANTICORPS ANTI-Tie2 HUMAIN | |
| BR112014008759A2 (pt) | tratamento de doença ocular | |
| PE20200011A1 (es) | ANTICUERPOS ANTI-PEPTIDO BETA AMILOIDE N3pGlu Y SUS USOS | |
| PE20181451A1 (es) | Anticuerpos neutralizadores del virus de inmunodeficiencia humana | |
| MX2017006323A (es) | Anticuerpos que comprenden regiones constantes pesadas modificadas. | |
| PE20181054A1 (es) | Anticuerpos anti-cd19 humano humanizados y metodos de utilizacion | |
| CR20140047A (es) | Dominios variables singulares anti-vgf fusionados con dominios de fc | |
| AR080026A1 (es) | Metodos de tratamiento de enfermedades autoinmunitarias con antagonistas del ligando 4 similar a delta (dll4) | |
| PE20080119A1 (es) | Anticuerpos anti-5ta y sus usos | |
| PE20161440A1 (es) | Variantes del anticuerpo anti-factor d y sus usos | |
| PE20141548A1 (es) | Anticuerpo anti-alfabeta tcr | |
| PE20190261A1 (es) | Anticuerpos que reconocen tau | |
| PE20141028A1 (es) | Nuevos moduladores y metodos para su uso | |
| PE20140448A1 (es) | Moleculas de union biespecificas que se unen a vegf y ang2 | |
| PE20081478A1 (es) | Anticuerpos cd44 | |
| PE20200695A1 (es) | Anticuerpos que reconocen tau | |
| PE20130528A1 (es) | PROTEINAS QUE SE UNEN AL TNF-alfa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |